Dupilumab Clinical Trials
39 recruitingDrug
Phase 210Phase 48Phase 36Early Phase 12Phase 12
Showing 1–20 of 39 trials
Recruiting
Phase 1Phase 2
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Non-small Cell Lung Cancer
Icahn School of Medicine at Mount Sinai21 enrolled1 locationNCT06088771
Recruiting
Phase 3
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals400 enrolled130 locationsNCT06868212
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Sanofi284 enrolled93 locationsNCT05263206
Recruiting
A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment
Dermatitis Atopic
Sanofi150 enrolled9 locationsNCT06192563
Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
Healthy Volunteers
Sanofi40 enrolled1 locationNCT07646548
Recruiting
Phase 2
Regeneron AA Multicenter (Dupilumab)
Alopecia Areata
Emma Guttman76 enrolled3 locationsNCT05551793
Recruiting
Phase 4
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Chronic Obstructive Pulmonary Disease
Sanofi218 enrolled68 locationsNCT07053423
Recruiting
Phase 4
Molecular Signatures of Cutaneous Dupilumab Response
Atopic Dermatitis
University of California, San Francisco15 enrolled1 locationNCT05858619
Recruiting
The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Sanofi184 enrolled2 locationsNCT07467564
Recruiting
Early Phase 1
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
TNBC - Triple-Negative Breast CancerLocally Advanced Triple Negative Breast Cancer
Rima Patel15 enrolled1 locationNCT06637306
Recruiting
Early Phase 1
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Skin Diseases
Northwestern University30 enrolled1 locationNCT05649098
Recruiting
Phase 4
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Sleep DisturbanceAtopic Dermatitis
Northwestern University40 enrolled1 locationNCT05042258
Recruiting
A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria
Sanofi400 enrolled1 locationNCT07316114
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
AsthmaWheezing
Sanofi90 enrolled74 locationsNCT06191315
Recruiting
Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Asthma
Sanofi1,324 enrolled249 locationsNCT05097287
Recruiting
Phase 2
A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.403 enrolled1 locationNCT07330934
Recruiting
A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany
eosinophilic esophagitis
Sanofi150 enrolled1 locationNCT06695897
Recruiting
Phase 2
Dupilumab Effects Against Aeroallergen Challenge
Asthma, Allergic
The University of Texas Health Science Center at San Antonio88 enrolled2 locationsNCT05720325
Recruiting
Phase 2
Dupilumab in the Treatment of Pediatric Alopecia Areata
Alopecia Areata
Icahn School of Medicine at Mount Sinai76 enrolled5 locationsNCT05866562